FDA Looks to Streamline Use of Experimental Treatments in Some Situations

FDA Looks to Streamline Use of Experimental Treatments in Some Situations-morningconsult: The Food and Drug Administration on Thursday issued a guidance to help physicians request expanded access to investigational drugs and biologics to treat patients with serious or immediately life-threatening diseases that don’t have other satisfactory cures.